Paul S. Herendeen

Valeant Pharmaceuticals International

Executive Vice President and Chief Financial Officer

Overview

Paul S. Herendeen received an average compensation of $16,986,237 at Valeant Pharmaceuticals International between 2016 and 2017.

Annual data

2017

Non-Equity Incentive Plan$1,590,000
Salary$1,000,000
Other$7,950
Total$2,597,950

In 2017, Paul S. Herendeen earned a total compensation of $2,597,950 as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International, Inc..

Herendeen received $1,590,000 in non-equity incentive plan, which accounts for 61.20% of total compensation.

Herendeen also received $1,000,000 in salary and $7,950 in other compensation.

Zoetis

Former Executive Vice President and Chief Financial Officer

Overview

Paul S. Herendeen received an average compensation of $2,408,443 at Zoetis from 2014 to 2016.

Annual data

2016

Bonus$300,000
Option Awards$666,667
Salary$445,962
Stock Awards$1,333,301
Other$103,072
Total$2,849,002

In 2016, Paul S. Herendeen earned a total compensation of $2,849,002 as Former Executive Vice President and Chief Financial Officer at Zoetis Inc..

Herendeen received $1,333,301 in stock awards, which accounts for 46.80% of total compensation.

Herendeen also received $300,000 in bonus, $666,667 in option awards, $445,962 in salary and $103,072 in other compensation.